CMH :: Clinical and Molecular Hepatology

Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals

Jagpreet Chhatwal, Ali Hajjar, Peter P. Mueller, Gizem Nemutlu, Neeti Kulkarni, Mary Linton B. Peters, Fasiha Kanwal

Clinical Gastroenterology and Hepatology.2024; 22(1): 91. CrossRef

Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial‐level analysis

The impact of waiting time and delayed treatment on the outcomes of patients with hepatocellular carcinoma: A systematic review and meta-analysis

Feng Yi Cheo, Celeste Hong Fei Lim, Kai Siang Chan, Vishal Girishchandra Shelat

Annals of Hepato-Biliary-Pancreatic Surgery.2024; 28(1): 1. CrossRef

Physics-based tissue simulator to model multicellular systems: A study of liver regeneration and hepatocellular carcinoma recurrence

Luciana Melina Luque, Carlos Manuel Carlevaro, Camilo Julio Llamoza Torres, Enrique Lomba, Roeland M.H. Merks

PLOS Computational Biology.2023; 19(3): e1010920. CrossRef

Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study

Sun Hong Yoo, Soon Sun Kim, Sang Gyune Kim, Jung Hyun Kwon, Han-Ah Lee, Yeon Seok Seo, Young Kul Jung, Hyung Joon Yim, Do Seon Song, Seong Hee Kang, Moon Young Kim, Young-Hwan Ahn, Jieun Han, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, J

Journal of Liver Cancer.2023; 23(1): 189. CrossRef

Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study

Hongmei Zeng, Maomao Cao, Changfa Xia, Dongmei Wang, Kun Chen, Zheng Zhu, Ruiying Fu, Shaokai Zhang, Jinyi Zhou, Huadong Wang, Xianyun Qi, Shuguang Dai, Yong Chen, Zhong Sun, Hao Ding, Qingwen Li, Hui Zhao, Xuehong Zhang, Jakub Morze, John S. Ji, Feng Sun

Threshold growth has a limited role in differentiating hepatocellular carcinoma from other focal hepatic lesions

Rong Lyu, Di Wang, Weijuan Hu, Zhongsong Gao, Changlu Yu, Jiao Wang, Mingge Li, Kefeng Jia

Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey

Hong Zhao, Aiping Zhou, Jianguo Zhou, Xinyu Bi, Shida Yan, Jing Jin, Wenqiang Wei, Muxing Li, Caifeng Gong, Qichen Chen, Zhiwen Luo, Ning Li, Rui Mao, Xiao Chen, Bo Chen, Rongshou Zheng, Jianjun Zhao, Yue Han, Zhiyu Li, Xu Che, Yuan Tang, Yongkun Sun, Zhe

Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk of Hepatocellular Carcinoma: A Retrospective Study

Damithri Ranathunga, Heba Osman, Nayaar Islam, Matthew D. F. McInnes, Javeria Munir, Christian B. van der Pol, Mohamed Elfaal, Cynthia Walsh

American Journal of Roentgenology.2022; 218(3): 462. CrossRef

Focal liver lesions in cirrhosis: Role of contrast-enhanced ultrasonography

Tommaso Vincenzo Bartolotta, Angelo Randazzo, Eleonora Bruno, Adele Taibbi

World Journal of Radiology.2022; 14(4): 70. CrossRef

Distinguishing excess mutations and increased cell death based on variant allele frequencies

Gergely Tibély, Dominik Schrempf, Imre Derényi, Gergely J. Szöllősi, Teresa M. Przytycka

PLOS Computational Biology.2022; 18(4): e1010048. CrossRef

The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry

Zobair M. Younossi, Yusuf Yilmaz, Mohamed El‐Kassas, Ajay Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez‐Sánchez, Wah Kheong Chan, Ashwani K. Singal, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian K. Price, Fatema Nader, Issah Younossi, And

Hepatology Communications.2022; 6(10): 2860. CrossRef

Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma

Maria Guarino, Valentina Cossiga, Mario Capasso, Chiara Mazzarelli, Filippo Pelizzaro, Rodolfo Sacco, Francesco Paolo Russo, Alessandro Vitale, Franco Trevisani, Giuseppe Cabibbo

Journal of Clinical Medicine.2022; 11(15): 4475. CrossRef

How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?

Islam H. Zaki, Erin Shropshire, Shuaiqi Zhang, Dong Xiao, Benjamin Wildman-Tobriner, Daniele Marin, Rajan T. Gupta, Alaattin Erkanli, Redon C. Nelson, Mustafa R. Bashir

SBRT for HCC: Overview of technique and treatment response assessment

Kimberly L. Shampain, Caitlin E. Hackett, Sohrab Towfighi, Anum Aslam, William R. Masch, Alison C. Harris, Silvia D. Chang, Kanika Khanna, Vivek Mendiratta, Ahmed M. Gabr, Dawn Owen, Mishal Mendiratta-Lala

Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells

Bhaskar Bhattacharya, Daniel Q. Huang, Sarah Hong Hui Low, Gim Hwa Tan, Min Ji Han, Sanamerjit Singh, Benny Tang, Sheng Chun Chang, Joey Sze Yun Lim, Mohd Feroz Mohd Omar, Yock Young Dan, Richie Soong

Exploration and time-serial validation of logistic regression models composed of multiple laboratory tests for early detection of HCV-associated hepatocellular carcinoma

Toshihiko Kobayashi, Kiyoshi Ichihara, Shuhei Goda, Isao Hidaka, Takahiro Yamasaki, Haku Ishida

Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?

Jae Hyon Park, Yong Eun Chung, Nieun Seo, Jin-Young Choi, Mi-Suk Park, Myeong-Jin Kim

Korean Journal of Radiology.2021; 22(10): 1628. CrossRef

Influence of pretreatment tumor growth rate on objective response of hepatocellular carcinoma treated with transarterial chemoembolization

Yvonne Purcell, Riccardo Sartoris, Valérie Paradis, Valérie Vilgrain, Maxime Ronot

Journal of Gastroenterology and Hepatology.2020; 35(2): 305. CrossRef

Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure

Pierleone Lucatelli, Gianluca De Rubeis, Luca Ginnani Corradini, Fabrizio Basilico, Michele Di Martino, Quirino Lai, Stefano Ginanni Corradini, Alessandro Cannavale, Pier Giorgio Nardis, Mario Corona, Luca Saba, Carlo Catalano, Mario Bezzi

European Journal of Radiology.2020; 124: 108806. CrossRef

Is delayed surgery justified for patients with hepatocellular carcinoma?

Zheng-Liang Chen, Ying-Jian Liang, Hao Xing, Tian Yang

Non‐invasive liver fibrosis scores are strongly associated with liver cancer mortality in general population without liver disease

Ki‐Chul Sung, Michael P. Johnston, Mi Y. Lee, Christopher D. Byrne

Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic

J.-J. Tuech, A. Gangloff, F. Di Fiore, P. Michel, C. Brigand, K. Slim, M. Pocard, L. Schwarz

Journal of Visceral Surgery.2020; 157(3): S7. CrossRef

Stratégie pour la pratique de la chirurgie digestive et oncologique en situation d’épidémie de COVID-19

J.-J. Tuech, A. Gangloff, F. Di Fiore, P. Michel, C. Brigand, K. Slim, M. Pocard, L. Schwarz

Journal de Chirurgie Viscérale.2020; 157(3): S6. CrossRef

Natural history of hepatocellular carcinoma after stereotactic body radiation therapy

Mishal Mendiratta-Lala, William Masch, Dawn Owen, Anum Aslam, Chris Maurino, Theresa Devasia, Matthew J. Schipper, Neehar D. Parikh, Kyle Cuneo, Theodore S. Lawrence, Matthew S. Davenport

Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis

Piyush Nathani, Purva Gopal, Nicole Rich, Adam Yopp, Takeshi Yokoo, Binu John, Jorge Marrero, Neehar Parikh, Amit G Singal

Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout?

Kyoung A. Baek, Seung Soo Kim, Hyeong Cheol Shin, Jeong Ah Hwang, Seo-Youn Choi, Woong Hee Lee, Chan Ho Park, Hyoung Nam Lee, Nam Hun Heo

Diagnostic performance of Liver Imaging Reporting and Data System in patients at risk of both hepatocellular carcinoma and metastasis

Min Jeong Cho, Chansik An, Khalid Suliman Aljoqiman, Jin-Young Choi, Joon Seok Lim, Mi-Suk Park, Hyungjin Rhee, Myeong-Jin Kim

Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification

Xuqi Sun, Lingling Li, Ning Lyu, Luwen Mu, Jinfa Lai, Ming Zhao

Prevention and control strategies of general surgeons under COVID-19 pandemic

Fenglin Liu, Weibin Wang, Hong Yu, Yong Wang, Wenming Wu, Xinyu Qin, Yupei Zhao

Surgery in Practice and Science.2020; 1: 100008. CrossRef

Liver Care and Surveillance: The Global Impact of the COVID‐19 Pandemic

Hidenori Toyoda, Daniel Q. Huang, Michael H. Le, Mindie H. Nguyen

Hepatology Communications.2020; 4(12): 1751. CrossRef

Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient‐Derived Xenograft Assays

Min Zhu, Lin Li, Tianshi Lu, Hyesun Yoo, Ji Zhu, Purva Gopal, Sam C. Wang, Matthew R. Porembka, Nicole E. Rich, Sofia Kagan, Mobolaji Odewole, Veronica Renteria, Akbar K. Waljee, Tao Wang, Amit G. Singal, Adam C. Yopp, Hao Zhu

Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival

David D. Lee, Gonzalo Sapisochin, Neil Mehta, Andre Gorgen, Kaitlyn R. Musto, Hana Hajda, Francis Y. Yao, David O. Hodge, Rickey E. Carter, Denise M. Harnois

Retrospective CT/MRI Texture Analysis of Rapidly Progressive Hepatocellular Carcinoma

Charissa Kim, Natasha Cigarroa, Venkateswar Surabhi, Balaji Ganeshan, Anil K. Pillai

Journal of Personalized Medicine.2020; 10(3): 136. CrossRef

LI-RADS Imaging Criteria for HCC Diagnosis and Treatment: Emerging Evidence

Anum Aslam, Richard Kinh Gian Do, Victoria Chernyak, Mishal Mendiratta-Lala

Current Hepatology Reports.2020; 19(4): 437. CrossRef

Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions

Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff, Mishal Mendiratta-Lala

World Journal of Hepatology.2020; 12(10): 738. CrossRef

Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis

Nicole E. Rich, Binu V. John, Neehar D. Parikh, Ian Rowe, Neil Mehta, Gaurav Khatri, Smitha M. Thomas, Munazza Anis, Mishal Mendiratta‐Lala, Christopher Hernandez, Mobolaji Odewole, Latha T. Sundaram, Venkata R. Konjeti, Shishir Shetty, Tahir Shah, Hao Zh

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Xuqi Sun, Dandan Hu, Yaojun Zhang, Ning Lyu, Li Xu, Qifeng Chen, Jinfa Lai, Minshan Chen, Ming Zhao

Journal of Hepatocellular Carcinoma.2020; Volume 7: 377. CrossRef

Impact of delayed time from diagnosis to treatment on the stage of hepatocellular carcinoma

Bing Quan, Wen-Tao Yan, Wan Yee Lau, Meng-Chao Wu, Tian Yang

Hepatobiliary & Pancreatic Diseases International.2019; 18(1): 100. CrossRef

Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up

Mishal Mendiratta-Lala, William Masch, Prasad R. Shankar, Holly E. Hartman, Matthew S. Davenport, Matthew J. Schipper, Chris Maurino, Kyle C. Cuneo, Theodore S. Lawrence, Dawn Owen

International Journal of Radiation Oncology*Biology*Physics.2019; 103(1): 169. CrossRef

A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma

Ruben Amoros, Ruth King, Hidenori Toyoda, Takashi Kumada, Philip J. Johnson, Thomas G. Bird

Discrepancy between the Actual Clinical Status of Patients with Hepatocellular Carcinoma and Expectations from Hepatocellular Carcinoma Surveillance: a Single-Center Study

Nak Min Kim, Young Seok Doh, Ji Woong Jang, Seok-Hwan Kim, Hyuk Soo Eun, Jae Hyuck Jun, Sae Hee Kim, Il Hyun Baek, Sung Hee Jung

Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS

Shin Hye Hwang, Sumi Park, Kyunghwa Han, Jin-young Choi, Young-Nyun Park, Mi-Suk Park

Combination Suicide Gene Delivery with an Adeno-Associated Virus Vector Encoding Inducible Caspase-9 and a Chemical Inducer of Dimerization Is Effective in a Xenotransplantation Model of Hepatocellular Carcinoma

Nusrat Khan, Sridhar Bammidi, Sourav Chattopadhyay, Giridhara R. Jayandharan

Bioconjugate Chemistry.2019; 30(6): 1754. CrossRef

Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response

Keungmo Yang, Pil S. Sung, Young K. You, Dong G. Kim, Jung S. Oh, Ho J. Chun, Jeong W. Jang, Si H. Bae, Jong Y. Choi, Seung K. Yoon

Historical Data Are Not Relevant to the Diagnostic Performance of Ultrasound in Surveillance for Hepatocellular Carcinoma

Contrast-enhanced ultrasound of malignant liver lesions

Isabelle Durot, Stephanie R. Wilson, Jürgen K. Willmann

Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease

Si Eun Lee, Chansik An, Shin Hye Hwang, Jin-Young Choi, Kyunghwa Han, Myeong-Jin Kim

Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis

Sally Ann Tran, An Le, Changqing Zhao, Joseph Hoang, Lee Ann Yasukawa, Susan Weber, Linda Henry, Mindie H Nguyen

BMJ Open Gastroenterology.2018; 5(1): e000192. CrossRef

Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time

Toshihiko Kasahara, Akira Miyauchi, Takumi Kudo, Eijun Nishihara, Mitsuru Ito, Yasuhiro Ito, Minoru Kihara, Akihiro Miya

Journal of Thyroid Research.2018; 2018: 1. CrossRef

Lydia S. Y. Tang, Emily Covert, Eleanor Wilson, Shyam Kottilil

Screening for hepatocellular carcinoma: What is missing?

Hepatology Communications.2017; 1(1): 18. CrossRef

Imaging of hepatocellular carcinoma and image guided therapies - how we do it

Jonathon Willatt, Julie A. Ruma, Shadi F. Azar, Nara L. Dasika, F. Syed

Men with biopsy‐confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population‐based study

Lars Bossen, Henning Grønbæk, Peter Lykke Eriksen, Peter Jepsen

Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice

Hepatology Communications.2017; 1(8): 723. CrossRef

Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma

Jong Kwan Kim, Hyung-Don Kim, Mi-Jung Jun, Sung-Cheol Yun, Ju Hyun Shim, Han Chu Lee, Danbi Lee, Jihyun An, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Kang Mo Kim

Digestive Diseases and Sciences.2017; 62(10): 2923. CrossRef

Liver Imaging Reporting and Data System: Review of Major Imaging Features

Irene Cruite, An Tang, Adrija Mamidipalli, Amol Shah, Cynthia Santillan, Claude B. Sirlin

Seminars in Roentgenology.2016; 51(4): 292. CrossRef

Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma

Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee

Journal of Gastrointestinal Surgery.2016; 20(11): 1807. CrossRef